PARPharmaceuticals

Par Technology CorporationQuarterly Results & Earnings

78.58
-7.53%
Profit Growth YoY-51.98%Latest quarter
Sales Growth YoY-17.31%Latest quarter
Sales CAGR 5Y12.57%5 year compound
Profit CAGR 5Y21.54%5 year compound
📋

Quarterly Performance

YoY Profit Growth-51.98%
🔴 Significant decline
YoY Sales Growth-17.31%
🔴 Significant decline
OPM 5Y Average
Operating profit margin
21.67%
EPS Growth 5Y
21.53%
Interest Coverage
Higher = safer debt servicing
131.90
ROE
13.62%
ROCE
18.35%
💡

Growth Analysis

Par Technology Corporation reported YoY profit growth of -51.98% and revenue growth of -17.31% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 12.57% and profits at 21.54% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.